Prestige Consumer Healthcare Inc. Reports Third Quarter Results
02. Februar 2023 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $275.5 Million in Q3 fiscal 2023 increased 0.4% versus Prior Year and 1.8% excluding CurrencyDiluted EPS of $1.04 for Q3 fiscal 2023 increased 5.1% versus Prior YearReduced leverage ratio...
Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
03. November 2022 06:00 ET
|
Prestige Consumer Healthcare Inc.
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding CurrencyDiluted EPS of $1.02 for Q2, ahead of expectationsReduced Debt by $35 million in Q2 and...
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
05. Mai 2022 16:30 ET
|
Prestige Consumer Healthcare Inc.
Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash FlowRevenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year,...
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
27. Mai 2021 08:30 ET
|
Prestige Consumer Healthcare Inc.
Acquisition adds TheraTears brand to Company’s leading eye care portfolioAcquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basisTransaction...
Prestige Consumer Healthcare Inc. Announces Offering of $500 Million Senior Notes
10. Februar 2021 07:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnings Results
08. Januar 2021 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results
05. November 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue was $237.4 Million in Second Quarter Fiscal 2021, Approximately Flat to Prior YearDiluted EPS of $0.88 in Second Quarter Fiscal 2021; Non-GAAP Adjusted Diluted EPS of $0.78 up 15% from Prior...
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 First Quarter Results
06. August 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue was $229.4 Million in First Quarter Fiscal 2021, Down 0.6% from Prior Year Q1 Excluding Unfavorable Foreign CurrencyDiluted EPS of $0.86 in First Quarter Fiscal 2021, up 32% from Prior Year...
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results
13. Juli 2020 16:45 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
07. Mai 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1 Million and Adjusted Free...